Literature DB >> 16024776

Death receptor-induced signaling pathways are differentially regulated by gamma interferon upstream of caspase 8 processing.

Daniela Siegmund1, Andreas Wicovsky, Ingo Schmitz, Klaus Schulze-Osthoff, Sebastian Kreuz, Martin Leverkus, Oliver Dittrich-Breiholz, Michael Kracht, Harald Wajant.   

Abstract

FasL and gamma interferon (IFN-gamma) are produced by activated T cells and NK cells and synergistically induce apoptosis. Although both cytokines can also elicit proinflammatory responses, a possible cross talk of these ligands with respect to nonapoptotic signaling has been poorly addressed. Here, we show that IFN-gamma sensitizes KB cells for apoptosis induction by facilitating death-inducing signaling complex (DISC)-mediated caspase 8 processing. Moreover, after protection against death receptor-induced apoptosis by caspase inhibition or Bcl2 overexpression, IFN-gamma also sensitized for Fas- and TRAIL death receptor-mediated NF-kappaB activation leading to synergistic upregulation of a variety of proinflammatory genes. In contrast, Fas-mediated activation of JNK, p38, and p42/44 occurred essentially independent from IFN-gamma sensitization, indicating that the apoptosis- and NF-kappaB-related FasL-IFN-gamma cross talk was not due to a simple global enhancement of Fas signaling. Overexpression of FLIP(L) and FLIP(S) inhibited Fas- as well as TRAIL-mediated NF-kappaB activation and apoptosis induction in IFN-gamma-primed cells suggesting that both responses are coregulated at the level of the DISC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024776      PMCID: PMC1190324          DOI: 10.1128/MCB.25.15.6363-6379.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Activation of caspase-3-like enzymes in non-apoptotic T cells.

Authors:  S Wilhelm; H Wagner; G Häcker
Journal:  Eur J Immunol       Date:  1998-03       Impact factor: 5.532

2.  The regulation of anoikis: MEKK-1 activation requires cleavage by caspases.

Authors:  M H Cardone; G S Salvesen; C Widmann; G Johnson; S M Frisch
Journal:  Cell       Date:  1997-07-25       Impact factor: 41.582

3.  Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes.

Authors:  David Holzberg; C Graham Knight; Oliver Dittrich-Breiholz; Heike Schneider; Anneke Dörrie; Elke Hoffmann; Klaus Resch; Michael Kracht
Journal:  J Biol Chem       Date:  2003-06-27       Impact factor: 5.157

Review 4.  Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system.

Authors:  Min Li-Weber; Peter H Krammer
Journal:  Semin Immunol       Date:  2003-06       Impact factor: 11.130

Review 5.  Fas-beyond death: a regenerative role for Fas in the nervous system.

Authors:  C Lambert; A M Landau; J Desbarats
Journal:  Apoptosis       Date:  2003-12       Impact factor: 4.677

6.  Activation of caspases-8 and -10 by FLIP(L).

Authors:  Kelly M Boatright; Cristina Deis; Jean-Bernard Denault; Daniel P Sutherlin; Guy S Salvesen
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

7.  Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.

Authors:  Francesco Grassi; Anna Piacentini; Sandra Cristino; Stefania Toneguzzi; Andrea Facchini; Gina Lisignoli
Journal:  Arthritis Rheum       Date:  2004-02

8.  N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway.

Authors:  Takao Kataoka; Jürg Tschopp
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.

Authors:  F C Kischkel; S Hellbardt; I Behrmann; M Germer; M Pawlita; P H Krammer; M E Peter
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

10.  NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP.

Authors:  Sebastian Kreuz; Daniela Siegmund; Jost-Julian Rumpf; Dierk Samel; Martin Leverkus; Ottmar Janssen; Georg Häcker; Oliver Dittrich-Breiholz; Michael Kracht; Peter Scheurich; Harald Wajant
Journal:  J Cell Biol       Date:  2004-08-02       Impact factor: 10.539

View more
  17 in total

1.  Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.

Authors:  Isabell Lang; Andrea Fick; Viktoria Schäfer; Tina Giner; Daniela Siegmund; Harald Wajant
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

2.  Antitumor activity and drug interactions of proteasome inhibitor Bortezomib in human high-risk myelodysplastic syndrome cells.

Authors:  Jian Huang; Ting Ding; Min Yang; Hui Liu; Xin Sun; Jie Jin
Journal:  Int J Hematol       Date:  2011-03-31       Impact factor: 2.490

3.  A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95.

Authors:  Constance Assohou-Luty; Jeanette Gerspach; Daniela Siegmund; Nicole Müller; Bertrand Huard; Gisa Tiegs; Klaus Pfizenmaier; Harald Wajant
Journal:  J Mol Med (Berl)       Date:  2006-08-04       Impact factor: 4.599

4.  TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development.

Authors:  Anne Grosse-Wilde; Oksana Voloshanenko; S Lawrence Bailey; Gary M Longton; Uta Schaefer; Andreea I Csernok; Günther Schütz; Erich F Greiner; Christopher J Kemp; Henning Walczak
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

5.  Synergistic interactions between interferon-gamma and TRAIL modulate c-FLIP in endothelial cells, mediating their lineage-specific sensitivity to thrombotic thrombocytopenic purpura plasma-associated apoptosis.

Authors:  Radu Stefanescu; Dustin Bassett; Rozbeh Modarresi; Francisco Santiago; Mohamad Fakruddin; Jeffrey Laurence
Journal:  Blood       Date:  2008-03-13       Impact factor: 22.113

Review 6.  TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them.

Authors:  Andrew Thorburn; Kian Behbakht; Heide Ford
Journal:  Drug Resist Updat       Date:  2008-04-18       Impact factor: 18.500

7.  Cellular FLICE-like inhibitory protein deviates myofibroblast fas-induced apoptosis toward proliferation during lung fibrosis.

Authors:  Regina Golan-Gerstl; Shulamit B Wallach-Dayan; Philip Zisman; Wellington V Cardoso; Ronald H Goldstein; Raphael Breuer
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-10       Impact factor: 6.914

Review 8.  Life in the Fas lane: differential outcomes of Fas signaling.

Authors:  Elizabeth Brint; Grace O'Callaghan; Aileen Houston
Journal:  Cell Mol Life Sci       Date:  2013-04-12       Impact factor: 9.261

9.  Potential for modulation of the fas apoptotic pathway by epidermal growth factor in sarcomas.

Authors:  David E Joyner; Kevin B Jones; Stephen L Lessnick; Joshua D Schiffman; R Lor Randall
Journal:  Sarcoma       Date:  2011-11-01

10.  Activation of the aryl hydrocarbon receptor sensitises human keratinocytes for CD95L- and TRAIL-induced apoptosis.

Authors:  K Stolpmann; J Brinkmann; S Salzmann; D Genkinger; E Fritsche; C Hutzler; H Wajant; A Luch; F Henkler
Journal:  Cell Death Dis       Date:  2012-09-06       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.